David Hung - 28 Feb 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: President and CEO, Director, 10%+ Owner
Signature: David Hung, by /s/ Kris Tsao Cachia, Attorney-in-Fact
Issuer symbol: NUVB
Transactions as of: 28 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2022, 13:29:41 UTC
Previous filing: 11 Jun 2021
Next filing: 10 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						58,646,800	28 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+2,000,000		$0.000000	2,000,000	28 Feb 2022	Class A Common Stock	2,000,000	$5.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,788 shares acquired on November 19, 2021 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.